Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

March 15, 2024; Volume 21,Issue 3

Editorials

  • Open Access
    Innate IgM antibodies to mannose in patients with gastric cancer
    Maxim Petrovich Nikulin, Nadezhda Vladimirovna Shilova, Alexander Dmitrievich Lipatnikov, Ivan Sokratovich Stilidi, Alexandra Vladimirovna Semyanikhina, Nikolai Vladimirovich Bovin and Nikolai Nikolaevich Tupitsyn
    Cancer Biology & Medicine March 2024, 21 (3) 193-197; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0156
  • Open Access
    Peptide drugs: a new direction in cancer immunotherapy
    Xinghua Sui, Xiaoshuang Niu, Xiuman Zhou and Yanfeng Gao
    Cancer Biology & Medicine March 2024, 21 (3) 198-203; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0297
  • Open Access
    Reducing the global cancer burden with gastrointestinal screening: China’s 30 years practice
    Lei Yang, Li Feng, Yong Zhu, Ning Wang, Xinpu Lu, Fanghui Gu, Xiaotian Zhang and Jiafu Ji
    Cancer Biology & Medicine March 2024, 21 (3) 204-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0516

Perspectives

  • Open Access
    Cervical cancer prevention in China: where are we now, and what’s next?
    Huijiao Yan, Qiankun Wang and Youlin Qiao
    Cancer Biology & Medicine March 2024, 21 (3) 213-217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0432
  • Open Access
    Current status of early gastric cancer screening research
    Can Hu, Li Yuan and Xiangdong Cheng
    Cancer Biology & Medicine March 2024, 21 (3) 218-222; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0377

Letter

  • Open Access
    A retrospective analysis of mature T- and NK-cell lymphomas
    Junlei Jia, Xiaohui Wang, Zheng Song, Shen Meng, Yue Fei, Jingwei Yu, Xia Liu, Xue Han, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, Xianhuo Wang and Huilai Zhang
    Cancer Biology & Medicine March 2024, 21 (3) 223-229; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0464

Review

  • Open Access
    Bronchoalveolar lavage fluid assessment facilitates precision medicine for lung cancer
    Hantao Zhang, Dan Deng, Shujun Li, Jing Ren, Wei Huang, Dan Liu and Weiya Wang
    Cancer Biology & Medicine March 2024, 21 (3) 230-251; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0381

Original Article

  • Open Access
    DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation
    Junya Yan, Shibo Wang, Jing Zhang, Qiangqiang Yuan, Xianchun Gao, Nannan Zhang, Yan Pan, Haohao Zhang, Kun Liu, Jun Yu, Linbin Lu, Hui Liu, Xiaoliang Gao, Sheng Zhao, Wenyao Zhang, Abudurousuli Reyila, Yu Qi, Qiujin Zhang, Shundong Cang, Yuanyuan Lu, Yanglin Pan, Yan Kong and Yongzhan Nie
    Cancer Biology & Medicine March 2024, 21 (3) 252-266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0303

Erratum

  • Open Access
    Erratum to Treatment strategies for patients with HER2-positive gastric cancer
    Feixue Wang and Yi Ba
    Cancer Biology & Medicine March 2024, 21 (3) 267; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0070
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 21 (3)
Cancer Biology & Medicine
Vol. 21, Issue 3
15 Mar 2024
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorials
  • Perspectives
  • Letter
  • Review
  • Original Article
  • Erratum

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire